Institute for Clinical Immuno-Oncology White Paper Highlights Challenges, Progress, Priorities in Immunotherapy
January 17, 2017
January 17, 2017
ROCKVILLE, Md., Jan. 17 -- The Association of Community Cancer Centers issued the following news release:
While momentum around immunotherapies for cancer continues to build, the high cost of these therapies places them at the center of debate about how best to define and measure value in cancer care. As these therapies are increasingly integrated into practice, all stakeholders--providers, patients, payers, and manufacturers--need to keep pace with emerging developments and real- . . .
While momentum around immunotherapies for cancer continues to build, the high cost of these therapies places them at the center of debate about how best to define and measure value in cancer care. As these therapies are increasingly integrated into practice, all stakeholders--providers, patients, payers, and manufacturers--need to keep pace with emerging developments and real- . . .